- About us
- Patient Stories
- Contact us
13 August 2012
Desiree Basila was 52 when her stage zero breast cancer — also called ductal carcinoma in situ — was diagnosed. While her cancer was found very early, she was ultimately diagnosed with the disease in both breasts. In addition, it was found in several locations. For Basila, doctors said her only realistic treatment option was double mastectomy — which Basila opposed. "If I die at 75 instead of 95 I think I can live with that," she told me recently. "I did not really want to have a double mastectomy."
Basila is strong evidence that individuals react differently to their treatment choices. The new healthcare buzzword is the engaged patient, generally referring to someone who is collaborating with doctors in the decision-making process and, conversely, where a patient's individual preferences are respected.
Basila became just such an engaged patient. After a cancer diagnosis, people usually have a few weeks to investigate treatment options, options that may be life altering. While Basila had little prior experience with cancer, she had been a science teacher and put her skills to use, digging into the research. She sought a second opinion at UC San Francisco and discovered a new research trial which appealed to her. Instead of double mastectomy, she enrolled in a trial on "Active Surveillance" of her slow-growing cancer. As part of the trial, she would go in twice a year for mammograms and she also received MRI images of her breasts once a year. "If it starts showing signs of aggression we can catch it and start more treatment at that point," she said.
In addition to the trial, Basila had support from the Decision Services group at UCSF. There, a newly-diagnosed cancer patient can elect to work with specially trained interns. These interns are often recent college graduates on their way to medical school or other health professions. They help patients find and review accurate information, determine their priorities, and create lists of questions. An intern may also accompany a patient as a note taker during medical appointments.
Such strategies have been been shown to improve patients' understanding of their cancer as well as their sense of engagement in their care. In a pilot program, [PDF] nine out of ten patients felt that the list of questions, concerns and expectations contributed to a more productive appointment with their doctor. Both patients and physicians reported satisfaction with these techniques.
But this decision support was available only to a fraction of the nation's cancer patients until earlier this summer, when the Open to Options program was launched by the Cancer Support Community. This new program was inspired by UCSF's decision-support service, and its counselors were trained by Professor Jeffrey Belkora, Director of Decision Services for the UCSF Breast Care Center.
The nonprofit Cancer Support Community (CSC) has a network of 150 locations across the country. The Open to Options program adds a toll-free phone number and other engagement tools to dramatically expand the reach of the services.
The new program targets patients who are "newly diagnosed, facing recurrence or at some other point during their survivorship when they're faced with making decisions," Belkora said. "After diagnosis but before treatment is a very vulnerable time for people. ... They're overloaded and overwhelmed."
Meanwhile, it's been five years since the self-described "risk-tolerant" Basila made her own decision. She admits her background in science made her diagnosis somewhat less confusing for her. After collaborating with decision-support interns, Basila said she felt she could "ask the right questions and give real thought to the answers. ... I didn't want my decision to be a reaction to fear." Although she lives with an "ongoing process" of decision, she hasn't wavered for the past five years. Her early stage breast cancer has not progressed and she is "thrilled" with her choice.
Active surveillance is common in prostate cancer but considered experimental for breast cancer. The outcome, while under study, is unknown. "Every one of us," Basila said, "has to decide what will be our quality vs. quantity of life."Eve Harris is a Bay Area health writer. The original post can be found here.